GenAssist Therapeutics is a leading base editing company founded in July 2020. Th headquarter is located in Suzhou (China), with subsidiaries in Shanghai (China) and Boston (US). GenAssist owns the global rights of TAM cytidine base editor, which was licensed from Chinese Academy of Nutrition and Health and Westlake University. The mission of GenAssist is to transform cutting-edging science into life-changing medicine.
Company Details
- Founded
- -
- Address
- 苏州, Cn
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.genassisttx.com
- HQ
- 苏州
Genassist Ltd Questions
Genassist Ltd's website is http://www.genassisttx.com
Genassist Ltd's LinkedIn profile is https://www.linkedin.com/company/genassist-ltd
Genassist Ltd's industry is
Biotechnology Research
Genassist Ltd's top competitors are
Argenx,
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.,
Newvalue Medical,
Healsun Biopharm,
Immunofoco,
Huidagene Therapeutics,
Doer Biologics,
Genassist,
Corregene Biotechnology,
Bc Marketing Consulting.
Genassist Ltd's categories are Biotechnology Research
Genassist Ltd's founding year is 2020
